P AMR

 A

The graphic is referencing a well-known set of estimates about antimicrobial resistance (AMR)—but it mixes a widely cited older figure with a projection, without the newer updates.

What it’s referring to

• The “700,000 deaths per year” figure comes from a 2016 report by the UK-led Review on Antimicrobial Resistance (often associated with economist Jim O’Neill).

• It estimated ~700,000 deaths annually worldwide due to drug-resistant infections at the time.

• The “10 million per year by 2050” is a projection from the same report, warning that AMR could become a leading global killer if trends continue.

What newer data shows

More recent research has refined those numbers:

• A major global study published in 2022 estimated:

  • ~1.27 million deaths directly attributable to AMR (in 2019)

  • ~4.95 million deaths associated with AMR (where resistance contributed)

So the situation today appears already worse than the older 700,000 estimate suggested.

Is the 10 million projection still valid?

• It’s still widely cited by organizations including the World Health Organization and others.

• But it is a scenario projection, not a measured prediction—it depends heavily on:

  • antibiotic use patterns

  • infection control

  • new drug development

  • global healthcare investment

Bottom line

• The graphic is directionally correct but simplified and partly outdated.

• The most accurate current view is:

  • AMR is already causing well over 1 million deaths per year

  • Without intervention, multi-million annual deaths by mid-century is plausible

A

1. What AMR really is

Bacteria evolve. When exposed to antibiotics:

• most bacteria die
• a few with random mutations survive
• those survivors multiply

Over time, antibiotics stop working for those strains.

It’s not bacteria “learning”—it’s natural selection under pressure.

---

2. The biggest driver: unnecessary antibiotic use

In humans

A large share of antibiotic use is:

• for viral infections (where antibiotics do nothing)
• prescribed “just in case”
• used too broadly instead of targeted treatment

Every unnecessary dose increases selection pressure.

---

In agriculture (a huge factor people often miss)

Globally, more antibiotics are used in animals than in humans in many regions.

They’re used for:

• disease prevention in crowded conditions
• growth promotion (still allowed in some countries)
• mass herd treatment

This creates a constant low-level exposure environment → ideal for resistant bacteria to emerge.

---

3. Hospitals: where resistance concentrates

Hospitals are hotspots because:

• high antibiotic use
• vulnerable patients
• invasive procedures (catheters, surgery, ventilators)

This is where “superbugs” like MRSA and drug-resistant Klebsiella spread.

Poor infection control (hand hygiene, sterilisation) accelerates outbreaks.

---

4. Why it spreads globally

Resistant bacteria don’t respect borders:

• travel
• food trade
• migration
• medical tourism

A resistant strain emerging in one place can become global within years.

---

5. The deeper problem: not enough new antibiotics

Drug development is failing because:

• antibiotics are used sparingly (so low profit)
• bacteria evolve faster than new drugs arrive
• pharmaceutical companies shifted focus to chronic disease drugs

So we’re losing effectiveness faster than we’re replacing it.

---

6. Why projections like “10 million deaths” exist

That estimate assumes:

• rising antibiotic misuse continues
• no major breakthrough drugs appear
• infection control improves only slowly

It’s not a prediction—it’s a warning scenario showing what happens if nothing changes.

---

7. What actually reduces AMR (this is the important part)

In healthcare

• rapid diagnostic testing (to avoid guessing antibiotics)
• narrower-spectrum antibiotics when possible
• strict hospital hygiene protocols

In agriculture

• reduced routine antibiotic use
• better animal density and hygiene
• vaccination of livestock instead of antibiotics

In society

• don’t demand antibiotics for viral illnesses
• complete prescribed courses correctly
• global surveillance of resistant strains

---

Bottom line

AMR isn’t caused by one thing—it’s a system problem:

• biology (evolution)
• medicine (overuse)
• agriculture (scale)
• economics (drug development incentives)

The “superbug crisis” isn’t inevitable—but without coordinated change, it becomes progressively harder to control.